Search research articles
Contact Us
Filters
Showing results (11-20 of 58) with videos related to
Page
of 6
Sort By:
Journal of Virology
|
November 29, 2013
Therapeutic depletion of natural killer cells controls persistent infection
Stephen N Waggoner, Keith A Daniels, Raymond M Welsh
Critical Reviews in Immunology
|
November 19, 2014
NK cells and their ability to modulate T cells during virus infections
Kevin D Cook, Stephen N Waggoner, Jason K Whitmire
JCI Insight
|
July 21, 2022
Ebola virus protein VP40 stimulates IL-12- and IL-18-dependent activation of human natural killer cells
Hung Le, Paul Spearman, Stephen N Waggoner, et al.
Journal of Leukocyte Biology
|
September 21, 2007
HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production
Stephen N Waggoner, Caroline H T Hall, Young S Hahn
Journal of Immunology (Baltimore, Md. : 1950)
|
September 24, 2005
gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway
Stephen N Waggoner, Michael W Cruise, Rachel Kassel, et al.
Nature
|
November 22, 2011
Natural killer cells act as rheostats modulating antiviral T cells
Stephen N Waggoner, Markus Cornberg, Liisa K Selin, et al.
Viral Immunology
|
December 27, 2007
Role of complement in immune regulation and its exploitation by virus
Kara L Cummings, Stephen N Waggoner, Robert Tacke, et al.
The Journal of Clinical Investigation
|
May 5, 2010
Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis
Stephen N Waggoner, Ruth T Taniguchi, Porunelloor A Mathew, et al.
Journal of Virology
|
May 28, 2004
Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt
Zhi Qiang Yao, Audrey Eisen-Vandervelde, Stephen N Waggoner, et al.
Trends in Pharmacological Sciences
|
July 27, 2021
Targeting natural killer cells to enhance vaccine responses
Andrew Cox, Hilal Cevik, H Alex Feldman, et al.
Page
of 6
Search research articles
Search
Showing results (11-20 of 58) with videos related to
Sort By:
Page
of 6
Journal of Virology
|
November 29, 2013
Therapeutic depletion of natural killer cells controls persistent infection
Stephen N Waggoner, Keith A Daniels, Raymond M Welsh
Critical Reviews in Immunology
|
November 19, 2014
NK cells and their ability to modulate T cells during virus infections
Kevin D Cook, Stephen N Waggoner, Jason K Whitmire
JCI Insight
|
July 21, 2022
Ebola virus protein VP40 stimulates IL-12- and IL-18-dependent activation of human natural killer cells
Hung Le, Paul Spearman, Stephen N Waggoner, et al.
Journal of Leukocyte Biology
|
September 21, 2007
HCV core protein interaction with gC1q receptor inhibits Th1 differentiation of CD4+ T cells via suppression of dendritic cell IL-12 production
Stephen N Waggoner, Caroline H T Hall, Young S Hahn
Journal of Immunology (Baltimore, Md. : 1950)
|
September 24, 2005
gC1q receptor ligation selectively down-regulates human IL-12 production through activation of the phosphoinositide 3-kinase pathway
Stephen N Waggoner, Michael W Cruise, Rachel Kassel, et al.
Nature
|
November 22, 2011
Natural killer cells act as rheostats modulating antiviral T cells
Stephen N Waggoner, Markus Cornberg, Liisa K Selin, et al.
Viral Immunology
|
December 27, 2007
Role of complement in immune regulation and its exploitation by virus
Kara L Cummings, Stephen N Waggoner, Robert Tacke, et al.
The Journal of Clinical Investigation
|
May 5, 2010
Absence of mouse 2B4 promotes NK cell-mediated killing of activated CD8+ T cells, leading to prolonged viral persistence and altered pathogenesis
Stephen N Waggoner, Ruth T Taniguchi, Porunelloor A Mathew, et al.
Journal of Virology
|
May 28, 2004
Direct binding of hepatitis C virus core to gC1qR on CD4+ and CD8+ T cells leads to impaired activation of Lck and Akt
Zhi Qiang Yao, Audrey Eisen-Vandervelde, Stephen N Waggoner, et al.
Trends in Pharmacological Sciences
|
July 27, 2021
Targeting natural killer cells to enhance vaccine responses
Andrew Cox, Hilal Cevik, H Alex Feldman, et al.
Page
of 6